EGIDE : Renforcement de la structure actionnariale et Remboursement de l’emprunt obligataire
December 20, 2023 02:00 ET
|
EGIDE
Communiqué de presse Bollène, 20 décembre 2023– 08h00 (CET) Renforcement de la structure actionnariale & Remboursement de l’emprunt obligataire Egide (Euronext Growth Paris™- ISIN : FR0000072373...
BRBS Shareholders Should Contact Robbins LLP the Blue Ridge Bankshares, Inc. Lawsuit
December 19, 2023 12:37 ET
|
Robbins LLP
Blue Ridge Bankshares, Inc. (BRBS) Has to Restate its Financial Statements due to Inadequate Internal Controls over Financial Reporting
Barclays PLC STOCK ALERT: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Class Action Against BCS
December 15, 2023 19:11 ET
|
Robbins LLP
Barclays (BCS) Misled Investors About the Relationship Between its CEO and Jeffrey Epstein
Egide: Successful capital increase with gross proceeds of 1.9 million euros
December 13, 2023 03:06 ET
|
EGIDE
Press release Bollène, December 12, 2023 – 8:00am (CET) A successful capital increase with gross proceeds of 1.9 million euros Subscription applications received for 4,462,513 new shares, i.e. a...
EGIDE : Succès de l'augmentation de capital d'un montant brut de 1,9 million d'euros
December 12, 2023 02:00 ET
|
EGIDE
Communiqué de presse Bollène, le 12 décembre 2023– 8h00 (CET) Succès de l’augmentation de capitald’un montant brut de 1,9 million d’euros Demandes de souscription portant sur 4 462 513 actions...
Castellum, Inc. Announces Execution of Debt Term Sheet
November 27, 2023 06:45 ET
|
Castellum, Inc.
Castellum, Inc. Announces Execution of Debt Term Sheet
EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany
November 23, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 23 novembre 2023 – 18:00 (CET) COMMUNIQUE DE PRESSE Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany EQUASENS, en association avec ARZ HAAN, un des leaders sur...
EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
November 23, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 23 November 2023 - 6:00 p.m. (CET) PRESS RELEASE Acquisition of the German company ADVand creation of PHARMAGEST Germany EQUASENS, in partnership with ARZ HAAN, a German market...
EQUASENS : Chiffre d’affaires du 3ème trimestre 2023
November 09, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 9 novembre 2023 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires du 3ème trimestre 2023 Chiffre d’affaires du T3 2023 : stable comparée au T3 2022 à 50,1 M€La...
Equasens: Q3 2023 revenue
November 09, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 9 November 2023 - 6:00 p.m. (CET) PRESS RELEASE Q3 2023 revenue Q3 2023 revenue: stable year-on-year at €50.1mGrowth impacted by: The completed deployment of solutions under...